Australian Institute for Bioengineering and Nanotechnology, The University of Queensland , Brisbane, QLD 4072, Australia.
J Am Chem Soc. 2017 May 10;139(18):6321-6328. doi: 10.1021/jacs.6b12622. Epub 2017 May 2.
Asymmetric mesoporous silica nanoparticles (MSNs) with controllable head-tail structures have been successfully synthesized. The head particle type is tunable (solid or porous), and the tail has dendritic large pores. The tail length and tail coverage on head particles are adjustable. Compared to spherical silica nanoparticles with a solid structure (Stöber spheres) or large-pore symmetrical MSNs with fully covered tails, asymmetrical head-tail MSNs (HTMSNs) show superior hemocompatibility due to reduced membrane deformation of red blood cells and decreased level of reactive oxygen species. Moreover, compared to Stöber spheres, asymmetrical HTMSNs exhibit a higher level of uptake and in vitro maturation of immune cells including dendritic cells and macrophage. This study has provided a new family of nanocarriers with potential applications in vaccine development and immunotherapy.
具有可控头尾结构的不对称介孔硅纳米粒子(MSNs)已被成功合成。头颗粒类型是可调的(实心或多孔),而尾部具有枝状大孔。尾部长度和头部颗粒上的尾部覆盖率是可调的。与具有实心结构的球形二氧化硅纳米粒子(Stöber 球)或尾部完全覆盖的大孔对称 MSNs 相比,不对称头尾 MSNs(HTMSNs)由于红细胞膜变形减少和活性氧水平降低,表现出更好的血液相容性。此外,与 Stöber 球相比,不对称 HTMSNs 表现出更高水平的免疫细胞(包括树突状细胞和巨噬细胞)摄取和体外成熟。本研究提供了一类新的纳米载体,具有在疫苗开发和免疫治疗中的潜在应用。